How to Prescribe Lidocaine 5% Patch (Lidoderm) for Localized Neuropathic Pain
Prescribe up to 3 lidocaine 5% patches applied once daily to intact skin covering the most painful area for up to 12 hours within a 24-hour period 1.
Specific Prescribing Instructions
Dosing Parameters
- Maximum number of patches: Apply up to 3 patches simultaneously 2, 3, 1
- Application duration: 12 hours on, 12 hours off within each 24-hour period 1
- Application site: Place directly on intact skin over the area of maximal pain 1
- Patch modification: Patches may be cut to smaller sizes with scissors before removing the release liner if needed to fit the painful area 1
Key Clinical Points
The lidocaine patch delivers medication gradually over hours, making it more effective than lidocaine cream or ointment 4. This sustained-release mechanism provides superior pain control with minimal systemic absorption 2, 3.
Safety Profile
- Systemic absorption is minimal even with up to 4 patches applied for 24 hours 3
- No clinically significant drug interactions have been documented 3, 5
- Adverse effects are rare and mild, primarily limited to local skin reactions (erythema, mild rash) 3, 5
- Contraindication: Advanced liver failure due to decreased lidocaine clearance 3
Special Populations
For debilitated patients or those with impaired elimination, recommend smaller treatment areas 1. The patch is particularly well-suited for elderly patients due to the absence of systemic toxicity and lack of drug interactions 3, 6.
Application Instructions for Patients
- Remove patches if irritation or burning occurs; do not reapply until irritation subsides 1
- Clothing may be worn over the application area 1
- When used with other local anesthetic products, consider total absorbed amount from all formulations 1
Expected Response Timeline
Approximately 66% of patients report improvement in pain intensity by Day 7, with an additional 43% of initial non-responders showing improvement by Day 14 7. The patch demonstrates efficacy regardless of time since herpes zoster onset 7.
Efficacy Evidence
The lidocaine 5% patch is FDA-approved specifically for postherpetic neuralgia 1 and has demonstrated effectiveness in controlled trials, though benefits may not match those of systemic gabapentin or tricyclic antidepressants 3. Clinical trials show approximately 60% of patients achieve moderate to complete pain relief 7.
Role in Treatment Algorithm
The lidocaine patch should be considered first-line therapy for localized neuropathic pain, either alone or combined with systemic agents 2, 7, 6. It acts locally as a co-analgesic and can be used alongside opioids, antidepressants, or anticonvulsants 2.
Common Pitfall to Avoid
Do not use the lidocaine patch for wound care—the manufacturer specifically warns against this off-label use 3. The patch is indicated only for intact skin 1.